APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/08/2026
Voltar para busca
Dado oficial do USPTO
NU.Q
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
10/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42
Data de depósito
03/04/2019
Data de registro
05/05/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/05/2020
Última transação
10/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
78
Localização do titular
BE
Examinador
BHUPATHI, TARA
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
B. S. (pessoa física)
Representantes
Megan Michaels Crowell & Moring LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and science; chemicals and other chemical preparations used in diagnostics for scientific or research use; chemical reagents for use in industry and science; chemicalbiological and diagnostic reagents for scientific or research usepreparations and substances for scientificdiagnostic and research purposesnamely reagentcellsenzymes; chemical and biological preparations and reagents for use in diagnostic and analytical testsincluding in vitro diagnostic laboratory tests; in vitro diagnostics preparationsdiagnostic reagents for in vitro laboratory use; reagents for life science scientific purposes
Classe 5
Pharmaceutical and diagnostic products and preparationspharmaceutical products for the treatment of cancer and cancer diagnostic preparations for medical purposes; medical diagnostic testing materialstest strips for use in the field of cancerreagents and assays for testing bodily fluids for cancer; diagnostic reagents for medical use; diagnostic reagentsreagents for medicinal use; diagnostic reagents for medical use; medical preparations for detection and diagnosis of cancer; medical preparations for detection and diagnosis of inflammation; stem cell differentiation status test preparations for medical purposes in the field of cancer diagnosistestingtreatment; chemicalbiological and diagnostic reagents and preparations for medical purposes in the field of cancer diagnosistestingtreatment; medical preparations for detection and diagnosis of diseases
Classe 10
Surgicalmedical and diagnostic apparatus and instrumentscancer diagnostic apparatus and instrumentsmedical apparatus for use in cancer surgery; diagnostic measuring apparatus for medical usediagnostic measuring apparatus for detecting cellular status; medical apparatusinstruments and equipment for use in the detection of cancer; in vitro diagnostic testing apparatus for medical use; in vitro diagnostic testing apparatus incorporating chemical reagentsfor medical use; medical apparatus for testing blood; medical apparatusinstruments and equipment for use in the detection of disease; parts and fittings for all the aforesaid
Classe 42
Scientific and technological servicesnamely scientific testing and analysis in the field of the detectiondiagnosis and treatment of cancer; industrial analysis of industrial fluids and industrial research services in the field of the detectiondiagnosis and treatment of cancer; research and developmentconsultancy and advisory services relating to biotechnologymedical technologymedical diagnostic assaysmedical diagnosticsmedical diagnostic reagentssubstancespreparations and materialsdetection of cancer and other diseases; analytical testing and diagnostic servicesnamely providing medical testing services and computer diagnostic servicesall in the field of cancer research and disease classification; design and development of medical diagnostic testing apparatus and reagents; blood analysis services; informationadvisoryconsultancy services relating to all the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
ES71
TEAS SECTION 71 RECEIVED
30/04/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/11/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/05/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2020
FIMP
FINAL DISPOSITION PROCESSED
11/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/02/2020
PUBO
PUBLISHED FOR OPPOSITION
18/02/2020
GPNX
NOTIFICATION PROCESSED BY IB
14/02/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/01/2020
ALIE
ASSIGNED TO LIE
16/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/01/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/12/2019
RFNT
REFUSAL PROCESSED BY IB
02/08/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/07/2019
RFRR
REFUSAL PROCESSED BY MPU
12/07/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/06/2019
CNRT
NON-FINAL ACTION WRITTEN
24/06/2019
MAFR
APPLICATION FILING RECEIPT MAILED
22/06/2019
DOCK
ASSIGNED TO EXAMINER
18/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NU.Q ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.